INTRODUCTION
Tissue formation during development depends on tightly regulated steps of progenitor cell self-renewal, transitory amplification of tissue-specific precursor cells, and their subsequent differentiation. The dynamic phenotypic changes that cells undergo during this process include major metabolic adaptation, as exemplified by skeletal muscle. Myogenic progenitors are characterized by the expression of Pax3 and Pax7, which are required both for maintenance of this stem cell population and for activation of Myf5 and MyoD, which control entry into the skeletal muscle program (Davis et al., 1987; Weintraub et al., 1991) . On activation of these myogenic determination genes, myoblasts proliferate before exiting the cell cycle, activating the myogenic differentiation gene, Myogenin, and forming multinucleated differentiated muscle fibers. Gene regulatory networks for both transcription factors and signaling pathways involved in myogenesis have been partially identified (Buckingham and Vincent 2009) ; however, important aspects of the myogenic context that affect cell behavior remain obscure. This is the case for the control of reactive oxygen species (ROS) that are produced by oxidative phosphorylation when cells switch from a glycolytic proliferative progenitor state to an oxidative postmitotic differentiated state (Remels et al., 2010; Blanchet et al., 2011) . The management of these by-products is critical as they can lead to oxidative stress and cell damage. In general, the control of ROS levels and of metabolic status is emerging as an important facet of stem cell biology, as illustrated by recent results on hematopoietic stem cells (Owusu-Ansah and Banerjee 2009; Takubo et al., 2010) . ROS levels were shown to increase at the onset of differentiation in immortalized muscle cell lines (Malinska et al., 2012; Lee et al., 2011) , but it is not clear whether this has functional significance in vivo or how it is regulated. Pitx2 and Pitx3, two genes expressed in muscle progenitor cells, have been associated in lens and retina with glaucoma and cataracts (Amendt et al., 1998; Semina et al., 1996 Semina et al., , 1997 , two disorders that involve oxidative stress (Babizhayev, 2012) . During myogenic development, these two genes lie downstream of Pax3/7 (Lagha et al., 2010; L'honoré et al., 2010) and upstream of the myogenic factor genes. While Pitx2 decreases at the onset of differentiation, Pitx3 is maintained in terminally differentiated cells. In Pitx3 mutants, muscle development is not notably perturbed. Pitx2 transcription, which is normally downregulated, is maintained in the absence of Pitx3, thus providing compensation .
In this report, we have investigated the roles of Pitx2 and Pitx3 during fetal myogenesis. Both in vivo by examining the muscle phenotypes of conditional Pitx2/Pitx3 double mutants and ex vivo in primary myogenic cell cultures, we observed a deficit in skeletal muscle due to cell death of myogenic cells at the onset of differentiation. We found an essential role for Pitx2 and Pitx3 in the management of ROS during the transition from proliferation to differentiation. In the absence of both Pitx factors, differentiating myoblasts accumulate abnormally high levels of ROS, leading to irreversible DNA damage and apoptosis. We demonstrate that this excessive level is largely due to deficient expression of the transcription factor nuclear respiratory factor 1 (Nrf1) and of its target genes implicated in mitochondrial respiration and in the antioxidant pathway. Using in vivo chromatin immunoprecipitation (ChIP), we show that Pitx2 and Pitx3 are direct regulators of both Nrf1 and its antioxidant targets, demonstrating two levels of ROS regulation by these transcription factors.
RESULTS
Absence of Pitx2/3 Impairs Skeletal Muscle Development In view of the apparent compensation of Pitx3 deficiency by Pitx2, we evaluated the involvement of both factors in fetal myogenesis using Pitx2:Pitx3 double conditional mutants. In contrast to embryonic myogenesis when only Pitx2 is expressed in Pax3-positive progenitors , during fetal myogenesis, both Pitx2 and Pitx3 are present in progenitors labeled by Pax7 (Figures S1A-S1F and S1M available online), and early differentiating cells marked by Myogenin (Figures S1G-S1L), before subsequent downregulation of Pitx2 in differentiated cells . In order to delete conditional alleles of these genes prior to the onset of myogenesis, we used the transgenic MSD-cre line, in which Cre recombinase is expressed throughout the paraxial mesoderm (Beckers et al., 2000) , or for differentiated muscle, an HSA-cre line where the human skeletal actin (HSA) promoter directs Cre expression (Miniou et al., 1999 S1R ) and is suggestive of inadequate development of the musculature, especially in the trunk (Grifone et al., 2005) . To analyze the consequences of deletion of Pitx2/3 genes, we first examined the development of trunk and limb skeletal muscles at E13.5 in the presence of the MSD-cre transgene. Wholemount in situ hybridization with a Myogenin probe showed a striking reduction in skeletal muscle in the body (Figures 1A and 1B) . As this reduction was not equal in all muscles, and to check the activity of the MSD-cre transgene, we performed the Pitx2 and Pitx3 deletion using the Pax3 cre/+ line. :MSD-cre mutants, demonstrating variable sensitivity of different muscles to the absence of Pitx2/3. In view of the coexpression of the two Pitx2/3 genes in progenitor cells and early differentiating cells, we then examined potential defects at both stages that might lead to the impairment in mutant muscle differentiation. Using TUNEL immunofluorescence staining, we observed a major increase in apoptosis in developing skeletal muscle in E12.5 mutant embryos crossed with the MSD-cre line ( Figures 1F-1H , 1L, and 1M), compared to control embryos . Such cell death is first detected at E11.5 (data not shown) and still observed in mutant embryos later during development at E16.5 ( Figures 1N and  1O ). We did not find any significant difference in the number of Pax7-positive progenitor cells in mutant versus control embryos at E13.5 ( Figure S1U ) and at E16.5 (data not shown), suggesting that the absence of Pitx2 and Pitx3 does not affect the proliferation or survival of Pax7-positive myogenic progenitors. Consistent with this, we did not detect an increased number of Pax7/ TUNEL double-positive cells in mutant embryos compared to controls ( Figures 1C, 1F , and 1L). However, we observed that a large proportion of cells that were undergoing apoptosis were also marked by Myogenin (61%) and MF20 (42%) expression ( Figures 1G, 1H , and 1L). We then examined the consequences of impaired expression of Pitx2 and Pitx3 in differentiated cells and did not detect any significant apoptosis in muscle masses of Pitx2 flox/flox :Pitx3
:HSA-Cre mutants either at E12.5 ( Figures 1I-1K and 1M ) or E16.5 ( Figure 1P ). Altogether, these data demonstrate that loss of Pitx2/3 gene expression in the myogenic lineage leads to impaired myogenesis due to apoptosis of cells at the onset of differentiation. Figure S2A ). We first validated the myogenic identity of green fluorescent protein (GFP)-sorted cells isolated from Pax3 GFP/+ embryos and confirmed that more than 98% of the cells expressed MyoD after 48 hr in culture ( Figure S2B ). Using immunocytochemistry with an antibody that recognizes both Pitx2 and Pitx3, and antibodies to MyoD, Myogenin, P21, and Troponin T, we showed that the pattern of expression of Pitx2/3 ex vivo in control Pax3 GFP/+ cells ( Figures  S2C and S2D) is similar to what we had previously observed in vivo (Figures S1A-S1L). After addition of 4-hydroxytamoxifen (4-OHT) to the culture medium ( Figure S2E ), recombination of both Pitx2 and Pitx3 alleles was complete after 36 hr of culture ( Figure S2F ), leading to the complete absence of Pitx2/3 staining by immunocytochemistry at 48 hr ( Figure S2G ). We then investigated the consequences of Pitx2/3 deletion on ex vivo myogenesis. Deletion of Pitx2 and Pitx3 genes affects expansion of the population (see DAPI in Figure 2A ) and leads to defective differentiation marked morphologically by the absence of multinucleated myotubes after 120 hr of culture ( Figure 2A , phase contrast), while 4-OHT treatment of control cells has no effect ( Figure S2H ). This phenotype is illustrated by the large reduction in Troponin T expression at 120 hr (Figures 2A and 2C ). We then followed sequential expression of progenitor and differentiating cell markers. We did not detect any differences in the number of progenitors marked by expression of Pax7 ( Figures S2I and S2K ). Unlike the situation during embryonic myogenesis in the limb (L'honoré et al., 2010) , MyoD is normally expressed in activated cells in the absence of Pitx2/3 ( Figures S2I and S2K ). The onset of differentiation occurs similarly in control and mutant cells, as shown by Myogenin expression at 72 hr ( Figures 2B and 2C) . However, by 96 hr, we observed a striking decrease (50%) in the mutant population compared to controls (Figures 2B and 2C) . This decrease is essentially due to a reduction in the number of Myogenin-positive cells in the mutant cultures, while the Myogenin-negative population is not affected ( Figure 2C ). This leads to an increased proportion of the Pax7-expressing cells in the population, as shown by reverse transcription followed by quantitative real-time PCR (qPCR) analysis of transcripts ( Figure 2D ).
Ex Vivo Deletion of
We observed a severe increase in apoptosis in mutant cells compared to controls ( Figures 2E and 2F Figures 1F-1H , 1L, and 1M). This apoptosis, marked by an increase of p53 and Noxa expression ( Figure 2G ), is first detected at the onset of differentiation, at 72 hr, and is high after 96 hr of culture ( Figure 2F ). Defects in cell cycle arrest at the onset of differentiation can lead to endoreplication of myotube nuclei and to their apoptosis (Zacksenhaus et al., 1996; Jiang et al., 2000) . As Pitx genes have been implicated in upregulation of p21 (Wei and Adelstein 2002; Cao et al., 2010) , we investigated whether Pitx2/3 mutant cells exit the cell cycle normally. At 72 hr, all Myogenin-positive cells were also marked by p21 expression in the presence or absence of Pitx2/3 ( Figures S3A and S3B) . Furthermore, mutant cells marked by Myogenin expression did not show increased 5-ethynyl 2 0 deoxyuridine (EdU) incorporation compared to controls ( Figures S3C and S3D ), demonstrating that, in the absence of Pitx2 and Pitx3, cells cease DNA synthesis and exit the cell cycle normally at the onset of differentiation. 
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Redox Regulation by Pitx2/3 during Myogenesis However, the phenotype of Pitx2/3 mutant cells in culture appeared even more pronounced than in vivo, with the nearly complete absence of differentiated cells after 120 hr of culture. These differences suggested that culture conditions exacerbated the mutant phenotype. Since our standard primary culture conditions are under atmospheric (20%) oxygen, we postulated that oxidative stress might be implicated in cell survival failure of Pitx2/3 mutant cells (Abbas et al., 2010) . We thus investigated whether mutant cells exhibited higher levels of intracellular ROS than their controls at the onset of differentiation. To purify progenitor and differentiating muscle cells from embryos, we took advantage of the relative stability of the GFP reporter that continues to be detectable at a lower level in Pax3 
Redox Regulation by Pitx2/3 during Myogenesis Pallafacchina et al., 2010) . Muscle cells from control and mutant embryos were separated by flow cytometry into Pax3
GFP-High ( Figure 3A , blue) and Pax3 GFP-Low ( Figure 3A , red) fractions and immediately processed for western blot analysis using Troponin T and phospho-histone-H3 antibodies ( Figure S3E ) or for ROS detection. Pax3
GFP-High and Pax3 GFP-Low populations of control and mutant cells were incubated with Cell Rox reagent, and the fluorescent signal was measured by flow cytometry (Figure 3A) . First, using control cells, we noted a significant increase 
Redox Regulation by Pitx2/3 during Myogenesis scavenges intracellular ROS (Richards et al., 2011) , completely reversed this upregulation ( Figure 3B ), demonstrating that deletion of Pitx2/3 genes leads to an increase of oxidative stress in differentiating cells. Excessive ROS levels can lead to DNA damage (Karanjawala et al., 2002) , which may trigger apoptosis if this reaches a critical threshold that compromises genomic stability (Shiloh, 2003) . In Pitx2/3 mutant cells, we found a significant increase of cells with gH2AX foci (Figures 3D and 3E) , markers of DNA damage signaling (Bonner et al., 2008 ), compared to the control. It is important to note that this increase occurs at the onset of differentiation (t = 72 hr), in Myogenin-positive cells (Figures 3D and 3F) and correlates with the high level of intracellular ROS ( Figures 3B and 3C ). Overall, these results suggest that the excessive level of ROS observed in myogenic cells depleted of Pitx2/3 is responsible for the accumulation of irreversible DNA damage, leading to subsequent cell apoptosis.
To reduce the oxidative stress, we first performed cultures under 3% O 2 . We observed a moderate reduction of apoptosis correlated with a small increase in differentiation in the absence of Pitx2/3 ( Figures 4A and 4B) ; indeed, the low oxygen conditions had a minor effect on the level of intracellular ROS ( Figure 4C ). To efficiently decrease this level, we supplemented the culture medium with the antioxidant NAC at day 0 of culture and then followed the survival and differentiation of control and mutant cells after culture under 20% ( Figures 4D-4H ) and 3% O 2 ( Figures 4F-4H ). NAC treatment performed either under 20% or 3% O 2 culture conditions efficiently reduced the number of gH2AX-positive cells in Pitx2/3 mutant cultures ( Figure 4G ), resulting in much less apoptosis of mutant cells ( Figure 4H ) and rescued differentiation ( Figures 4B and 4C) . Similar results were obtained using two different antioxidants, Trolox and Resveratrol ( Figures S4A and  S4B ), thus demonstrating that the abnormal increase of ROS levels observed in cells depleted for Pitx2/3 is directly responsible for their altered terminal differentiation.
Pitx2/3 Fine-Tune the Expression of the Antioxidant System through Regulation of Nrf1 and Antioxidant Enzymes during Differentiation ROS are formed as by-products of aerobic respiration and are mainly generated by the mitochondrial respiratory chain. Myogenic differentiation is accompanied by major metabolic changes, when cells switch from a glycolytic proliferative progenitor state to an oxidative postmitotic differentiated state (Remels et al., 2010; Blanchet et al., 2011) . Such changes require extensive mitochondrial biogenesis that takes place at the onset of differentiation and leads to increased ROS production (Figure 3A ; Malinska et al., 2012) . To protect cells from oxidative damage, this intracellular oxidant activity needs to be balanced by an antioxidant system composed of scavenging and detoxifying enzymes (Sena and Chandel, 2012) . It is interesting that Aldh1a1, encoding Aldehyde dehydrogenase 1a1, an enzyme that detoxifies oxidized aldehydic products (Vasiliou et al., 2004; Jean et al., 2011) , had been identified previously as a direct target of Pitx3 in midbrain dopaminergic neurons (Jacobs et al., 2007) . We therefore investigated whether Pitx2/3 may regulate part of the antioxidant system in muscle cells leading to increased ROS levels in their absence. We first assessed in vivo expression of the antioxidant system. Pax3
GFP-High and Pax3
GFP-Low fractions were isolated from control E13.5
Pax3 GFP/+ embryos and processed for mRNA extraction. Transcript levels for markers of mitochondrial function (Cox5a, NdUfv1; Bourens et al., 2013) and oxidative metabolism (PGC1a, Eno3; Patti et al., 2003) demonstrated the metabolic shift occurring at the onset of differentiation in Pax3
GFP-Low cells ( Figures 5A and S5A) . We found significant upregulation of antioxidant genes in these cells compared to Pax3 GFP-High progenitor cells ( Figures 5A and S5A ), thus establishing a direct correlation between the metabolic shift occurring at the onset of differentiation and the activation of the antioxidant system. We then examined the kinetics of this coregulation ex vivo. Consistent with the in vivo results, most of the antioxidant genes were found to be upregulated at 72 hr of culture, when the major onset of differentiation occurs and the expression of both Pitx2/3 genes increases ( Figure S5B ). We next investigated whether this activation occurs normally during differentiation of Pitx2/3 mutant cells. Quantification of mRNA levels after 72 hr of culture revealed an upregulation of transcripts for Gpx3 and PGC1a in mutant cells ( Figure 5B ), an expected response to the abnormal increase of ROS (Ufer and Wang, 2011) . We also observed a concomitant and consistent decreased expression of Aldh1a1, Mt1, Gsta1, Nrf1, and SOD1 in mutant cells compared to controls both at mRNA ( Figure 5B ) and at protein levels ( Figure 5D ). This decrease was confirmed in vivo in Pax3 GFP-Low cells isolated from control and mutant embryos ( Figure 5C ) and, as expected, leads to a significant reduction of the total antioxidant capacity (TAC) of differentiating Pitx2/3 mutant cells both in vivo and ex vivo ( Figures 5E and S5C) .
We next investigated the molecular mechanism underlying the decreased expression of this antioxidant system in Pitx2/3-depleted cells. In silico analysis shows that the promoters of antioxidant genes such as SOD1, Mt1, Gsta1, and Aldha1a also have binding sites for the nuclear respiratory factor 1 (Nrf1) (Satoh et al., 2013) , now commonly abbreviated as NRF1 but referred to here as Nrf1. In view of the downregulation of Nrf1 in Pitx2/3 mutant cells ( Figure 5B ), we postulated that Pitx2/3 might regulate antioxidant genes through the direct activation of Nrf1. Using ChIP on E13.5 embryos, we first showed a strong recruitment of Pitx2/3 on Pitx response elements (PitxRE) local-ized in regulatory regions of Nrf1 ( Figure 5F ). Pitx2 and Pitx3 can transactivate these regions in a heterologous cell system, and mutations of both PitxRE completely abolish this activation ( Figure 5G ). We found a similar activation of the Aldh1a1 promoter by Pitx2 and Pitx3, consistent with strong recruitment of both Pitx2/3 on these sequences in vivo ( Figure 5H ). We also observed direct binding of Nrf1 to Mt1, SOD1, and Gsta1 regulatory regions in vivo ( Figure 5H ). Analysis of the Aldh1a1 promoter revealed the presence of a nuclear respiratory factor binding site, and efficient binding of Nrf1 to this sequence was confirmed ( Figure 5H ), suggesting a possible coregulation of antioxidant genes by both Pitx2/3 and Nrf1. To investigate this hypothesis, we searched in silico for PitxRE near nuclear respiratory factor binding sites and identified the presence of both sites in the regulatory environment of Mt1, SOD1, and Gsta1 genes, in agreement with our ChIP identification of Pitx2/3 on these regulatory regions ( Figure 5H ). Taken together with our analysis of ROS levels in control and mutant cells ( Figures 3A-3C ), these results thus support a two-level regulation of the antioxidant pathway by Pitx2/3 ( Figure 5I ), occurring at the onset of differentiation when high metabolic needs require extensive
Redox Regulation by Pitx2/3 during Myogenesis mitochondrial biogenesis. To investigate whether such regulation can also occur in the absence of metabolic demand, control and mutant cells were treated when still proliferating, after 36 hr of culture, with buthionine sulfoximine (BSO), an inhibitor of g-glutamylcysteine synthetase (Griffith 1982) to deplete glutathione (GSH). In contrast to control cells in which such depletion ( Figure S5E ) leads to significant induction of the antioxidant pathway ( Figure S5F) , and thus moderate increase of ROS levels and apoptosis ( Figures S5G and S5H) , analysis of Pitx2/3 mutant cells revealed a defective activation of this pathway leading to a large increase of ROS levels and cell death after 18 hr of treatment ( Figures S5G and S5H ). These results demonstrate the essential role of Pitx2 and Pitx3 in the activation of antioxidant genes in response to high levels of ROS induced either by increase of metabolic activity during differentiation or acute induced oxidative stress.
Pitx2/3 Mutant Cells Exhibit Defective Mitochondrial Function, Leading to Overproduction of ROS during Differentiation
To investigate whether the defective activation of the antioxidant pathway is sufficient to induce the abnormally high levels of intracellular ROS observed in Pitx2/3 mutant cells, wildtype fetal cells isolated from Pax3 GFP/+ embryos were transfected with siRNA directed against SOD1, Mt1, and Gsta1 transcripts ( Figure 6A ). Efficient inhibition of the expression of these three genes ( Figure S6A ) leads to severe apoptosis of cells after 96 hr of culture ( Figure 6C ), as a consequence of an increase of ROS levels ( Figure 6B) ; however, while significant, this increase does not reach that of Pitx2/3 mutant cells. This result suggested that the defective expression of scavenging enzymes was not sufficient to induce the high ROS levels of Pitx2/3-deficient cells. In addition to its regulation of antioxidant genes, Nrf1 also plays a key role in integrating the transcription of nuclearand mitochondrial-encoded genes. Nrf1 target genes include subunits of the mitochondrial respiratory complexes such as cytochrome C, and the transcription factor A Tfam, which transcribes the mitochondrial genome (Kelly and Scarpulla, 2004) . As alteration in expression of these genes can lead to mitochondrial dysfunction, a major cause of ROS overproduction, we investigated their expression in Pitx2/3 mutant cells. Quantification of their transcripts both in vivo in Pax3 GFP-Low cells isolated from control and mutant embryos ( Figure 6D ) and ex vivo after 72 hr of culture ( Figure S6B ) revealed a consistent decrease of their expression as well as that of two Tfam target genes Ndufv1 and Ndufb6. We then investigated markers of mitochondrial function in mutant cells compared to controls and observed an alteration of the cellular bioenergetic state as evidenced by the decrease in the NAD+/NADH ratio ( Figures  6E and S6C ), together with a reduction in the intracellular ATP content ( Figure 6F ). Quantification of mitochondrial ROS by incubation of cells with Mitosox after 72 hr of culture revealed a higher rate of ROS production in mutant cells compared to controls (Figure 6G) . Overall, these results suggest that, in Pitx2/3 mutant cells, the altered expression of Nrf1 and of its target genes is responsible for both mitochondrial dysfunction, leading to ROS overgeneration, and concomitant defective expression of the antioxidant system, leading to decreased ROS scavenging. As these two events occur at the onset of differentiation, when high metabolic needs require increased oxidative phosphorylation, we investigated whether inhibition of mitochondrial biogenesis, and thus of oxidative phosphorylation, by depletion of Tfam (Lee et al., 2011 ) might prevent mutant cell differentiation and their apoptosis. Pitx2/3 mutant cells were transfected with siRNA directed against Tfam ( Figure 6H ). As expected, the inhibition of Tfam expression ( Figure S6D ) prevented mutant cell differentiation ( Figure 6I ), leading to an increase in cell number by maintenance of proliferation and to a significant rescue of apoptosis ( Figure 6J ). To confirm the direct correlation between Nrf1 downregulation and the phenotype of Pitx2/3-deficient cells, we restored Nrf1 expression in mutant cells through lentiviral infection. As expected, Nrf1 overexpression ( Figure S7A ) prevented the abnormal increase of ROS ( Figure 7C ) both by activating the expression of the antioxidant system and by preventing mitochondrial dysfunction through rescued expression of Tfam ( Figure S7B ). This resulted in a significant rescue of the differentiation of mutant cells, as evidenced by Troponin T expression ( Figures 7A and 7B ) and the level of Myogenin transcripts (Figure S7A) . We therefore conclude that Pitx2/3, through their control of the Nrf1 gene, are critical regulators of the redox state of myogenic cells and that this is necessary for their survival and their differentiation.
DISCUSSION
Our analysis of the role of Pitx2 and Pitx3 during fetal myogenesis reveals an essential role in regulation of intracellular redox levels during differentiation ( Figure 7D ). In their absence, ROS accumulate to pathological levels at the onset of differentiation, leading to DNA damage and consequent death of differentiating cells ( Figure 7E ).
Major metabolic changes occur as cells become more specialized within a differentiated lineage. In the case of myogenic cells, these changes are of particular interest, specifically as cells switch from a glycolytic proliferative progenitor state to an oxidative postmitotic differentiated state. Previous studies have correlated this metabolic shift with an increase of intracellular ROS levels in immortalized adult cell lines (Malinska et al., 2012; Lee et al., 2011) . However, very little is known about redox levels of myogenic cells in vivo during development or about the regulation of genes involved in ROS control (Sena and Chandel, 2012) . We have found an increase of ROS levels occurring in vivo at the onset of differentiation and have identified the Pitx2/3 transcription factors as essential regulators of this process. In Pitx2/3 mutant muscle cells, ROS increase is deregulated, leading to excessive accumulation of ROS and further cell death. We have shown that this is due to downregulation of the nuclear respiratory factor 1 (Nrf1), a transcription factor that is essential for the coordination of mitochondrial function (Kelly and Scarpulla, 2004 ) and that we identified as critical for the finetuning of the level of antioxidant enzymes. The decreased expression of Nrf1 and a subset of its targets are responsible for both impaired mitochondrial activity leading to ROS overgeneration and deficient activation of the antioxidant pathway ( Figures 7C and 7D) . Furthermore, using ChIP, transactivation assays, and lentiviral rescue, we show direct regulation of Nrf1 by Pitx2/3 with joint binding of Nrf1 and Pitx2/3 on downstream antioxidant target genes. These results place Pitx2/3 as core regulators of redox control during myogenic differentiation.
It is interesting that expression of the detoxifying enzyme, Aldh1a1, is downregulated in Pitx2/3 mutant muscle and that direct regulation by Pitx3 was also shown in midbrain dopaminergic neurons (Jacobs et al., 2007) RNA samples were analyzed by qPCR for transcripts of proliferation markers, myogenic transcription factors, antioxidant enzymes and transcription factors, and mitochondrial and metabolic genes, relative to the level of Gapdh transcripts. The data are represented as a heat map.
(legend continued on next page)
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Redox Regulation by Pitx2/3 during Myogenesis (Varç in et al., 2011) . Similarly in the eye, in both the retina where Pitx2 is expressed and in the Pitx3-positive lens, mutations in mice and humans have been associated with downregulation of Aldh1a1 (Paylakhi et al., 2011) and with glaucoma and cataracts (Amendt et al., 1998; Semina et al., 1996 Semina et al., , 1997 , two disorders in which oxidative stress has also been implicated (Babizhayev, 2012) . We therefore speculate that the regulation of the redox state that we have identified during fetal myogenesis is a common property of Pitx transcription factors at their different sites of expression.
In vivo, the cell death that we observed in developing fetal muscle masses in the absence of Pitx2/3 leads to a striking deficit in skeletal muscle. This is observed when the conditional Pitx2/3 alleles are mutated early in paraxial mesoderm, using the MSD-Cre line, but not when the deletion occurs in differentiated muscle fibers, using the HSA-Cre line. This is consistent with a role of Pitx2/3 in activation of the antioxidant pathways through Nrf1 and its target genes and with their role at the onset of differentiation. Embryonic and fetal myoblasts have characteristic properties (Biressi et al., 2007) , and distinct transcriptional regulators of embryonic and fetal muscle differentiation have begun to be identified (Hutcheson et al., 2009; Messina et al., 2010) . Expression of the myogenic determination gene MyoD is not compromised in the Pitx2/3 mutant at fetal stages, a phenotype that differs from that in embryonic muscle, where Pitx2, acting downstream of Pax3, is required for MyoD expression through direct activation of the MyoD embryonic enhancer (L'honoré et al., 2010) . These different functional requirements for Pitx factors underline the differences between embryonic and fetal myogenesis. In the context of oxidative stress, with the introduction of the chorio-allantoic circulation, the fetus is exposed to higher oxygen levels (Ufer and Wang, 2011) , making it more vulnerable to the increase of ROS observed in the absence of Pitx2/3 than during embryonic myogenesis when it is less deleterious.
During fetal myogenesis, we show that ROS levels become abnormally high at the onset of differentiation in the absence of Pitx2/3, leading to accumulation of DNA lesions marked by gH2AX foci in Myogenin-positive cells. DNA lesions due to oxidation are processed by the base excision repair pathway (Narciso et al., 2007) . In myogenic cells, this pathway is activated in proliferating cells before differentiation and involves cell cycle arrest coupled with a transient block of transcription of musclespecific genes referred to a differentiation checkpoint (Puri et al., 2002) . Such a mechanism, which would permit genome repair before the differentiation program begins, is no longer present in differentiating cells (Narciso et al., 2007) . We provide evidence that myogenic cells at the onset of differentiation, which cannot activate the base excision repair pathway, rely upon apoptosis as a cellular response to oxidative DNA damage.
In conclusion, the myogenic system clearly illustrates the importance of regulating the redox state at the onset of cell differentiation. During fetal myogenesis, Pitx2/3 control this redox state through the regulation of Nrf1 and of antioxidant pathways. Their absence results in a major upregulation of ROS levels which reach a pathological threshold with consequent death of differentiating cells. The Pitx2/3 transcription factors are thus key regulators of the intracellular redox state during development. , HSA-Cre, and MSD-cre mice were generously given by J. Epstein (Engleka et al., 2005) , J. Melki (Miniou et al., 1999), and A. Gossler (Beckers et al., 2000) , respectively. The experiments were performed with three independent cultures, and a representative experiment is shown.
(E) Antioxidant total capacity was measured (n = 3 embryos; mean ± SD, *p < 0.05). Whole-Mount In Situ Hybridization and X-Gal Staining Mouse embryos were collected after natural overnight mating. Noon of the day on which a vaginal plug was detected was considered as E0.5, and embryos were staged by counting the number of somites. Whole-mount in situ hybridization was performed as previously described (L'honoré et al., 2010) , using digoxigenin-labeled riboprobes for Myogenin. Whole-mount X-Gal and whole-mount antibody staining were performed as described elsewhere ; Gré goire and Kmita, 2008) with modifications (see Supplemental Information).
Immunohistochemistry, Immunofluorescence, and Western Blot Western blot, immunohistochemistry, and immunofluorescence were carried out as described elsewhere Relaix et al., 2006) . Antibodies and kits used for TUNEL assay and EdU staining are detailed in the Supplemental Information. GFP and Tomato detection and pictures were obtained using an Apotome.
Primary Cell Purification and Culture E13.5 embryos were dissected to obtain trunk and limbs. Care was taken to eliminate internal organs and the neural tube. Embryo tail fragments were (D) RNA was analyzed by qPCR for transcripts of Tfam and respiratory chain components relative to Gapdh transcripts in mutant (mut) /control (ctrl) cells, expressed as a log ratio (n = 2 embryos; mean ± SD, *p < 0.05).
(E) Pax3 GFP-Low cells were used after purification for quantification of the NAD+/NADH ratio (n = 2 embryos; mean ± SD, *p < 0.05). conserved for genotyping. Cells were then prepared and cultured as described elsewhere (Montarras et al., 2005; Relaix et al., 2006) with modifications (see Supplemental Information). 4-OHT was prepared and used as described elsewhere (Lepper et al., 2009 ) with modifications (see Supplemental Information). NAC (Sigma) was diluted at 0.5 M in H 2 O before each experiment and used for cell seeding at 5 mM in growth medium or added to cell culture at 10 mM 3 hr before Cell Rox analysis. Resveratrol (Enzo Life Sciences) was diluted at 0.05 M in EtOH before each experiment and added to cell culture at 25 mM. Trolox (Abcam) was stored as a 1 mM solution at À20 C in DMSO and added at 10 mM to cell cultures. BSO (Enzo Life Sciences) was diluted at 5 mM in H 2 O before each experiment and added to cell cultures at 10 mM.
RNA Extraction and Quantitative Real-Time PCR Analysis
Cells were collected after flow cytometry in RLT buffer (QIAGEN) for RNA extraction or plated on gelatin-coated dishes in growth medium supplemented, or not supplemented, with 4-OHT and/or NAC before RNA extraction. Total RNA was extracted and purified after DNase treatment (Promega) using the RNAeasy Micro kit (QIAGEN) and was reverse-transcribed into cDNA, based on instructions provided by the Transcriptor cDNA synthesis kit (Roche). Quantitative real-time PCR was performed on a StepOnePlus PCR machine (Applied Biosystems) using the FastStart Universal SYBR Green Master (Roche).
Metabolic Analysis
ROS quantification was performed by microscopy or flow cytometry using the Cell ROX and the MitoSOX probes (Invitrogen). The following kits were used for metabolic analysis according to manufacturer's instructions: TAC kit (Abcam), GSH colorimetric detection kit, and NAD+/NADH detection and ATP quantification kits (BioVision). For details about these methodologies, see Supplemental Information.
ChIP ChIP was performed as described elsewhere Navarro et al., 2010) with modifications (see Supplemental Information).
Lentiviral Production, Cell Infection, siRNA Transfection, and Transactivation Assays Lentiviral vectors CMV-NRF1-RFP-2A and RFP-2A were purchased from abm. siRNA were purchased from Origene (Tfam) and Santa Cruz Biotechnology (Mt1, Gsta1, SOD1). Tfam and Aldh1a1 promoter mutants were generated using a commercial kit (Stratagene) according to the manufacturer's instructions and transfected into 293 cells. Details about these methodologies can be found in the Supplemental Information.
Statistical Analysis
All experiments were carried out on a minimum of three embryos. All data are presented as mean and SD. The Student's t test was applied. A p value < 0.05 was considered statistically significant. 
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